They may note a mottled appearance caused by pigmentary changes in the macula. In the early stage of macular degeneration, your healthcare provider may find drusen. These are yellow-colored deposits ...

Worldwide, age-related macular degeneration (AMD) is the leading cause of severe vision loss in people aged 50 or older. Neovascular AMD is an advanced form of the condition, also known as “exudative ...

Have your parents or grandparents ever had trouble driving, reading or recognizing faces? They might be suffering from age-related macular degeneration, a progressive disease afflicting about 11 ...

A study from researchers at Wilmer Eye Institute, Johns Hopkins Medicine explains not only why some patients with wet ...

The Food and Drug Administration will allow a new device to be marketed as a treatment for dry age-related macular degeneration.

Nutritional supplements that contain curcumin -- a natural anti-inflammatory compound -- may protect the eyes from the ...

Reduced well-being and loss of productivity were contributors to the high economic burden in patients with late-stage age-related macular degeneration (AMD) living in the US, Germany, and Bulgaria.

Curcuma-based nutritional supplements (CBNS) have been scientifically established to possess antioxidant and ...

TUESDAY, Nov. 5, 2024 (HealthDay News) -- Current treatments sometimes fail to help people with “wet” age-related macular degeneration-- and researchers now think they know why. Wet AMD is caused by ...

Australian scientists have successfully used an innovative gene therapy technique in the lab to combat a key cause of vision ...

Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for inherited retinal ...

HuidaGene Therapeutics (HuidaGene), a global clinical-stage biotechnology company developing genome medicines, announced that the US FDA has cleared its HG202 investigational new drug (IND) ...